Physician

Mark D Lafuria, MD

According to 2025 Medicare claims, Mark Lafuria, MD (NPI: 1427181908) practices internal medicine in the Lake Charles, LA market, with the plurality of this provider's patient population coming from Calcasieu, LA. This provider's primary affiliated billing organization is SWLHS LLC (NPI: 1669494654; TIN: 721103283) and primary practice location at 70601-8994. Lafuria is affiliated with the Health Leaders Network of Mississippi LLC (ACO ID: A5148), participating under the MSSP model.

Lafuria's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 706 traditional Medicare patients, billed 5,117 HCPCS/CPT codes, and received $275,112 in Medicare payments. The top billing code was 99306 (Initial nursing facility care with high level of medical decision making, per day, if using time, 50 minutes or more). Part D data shows 28,959 prescription claims across 760 beneficiaries totaling $2,245,169 in drug costs, led by Eliquis (Apixaban). DME data shows 478 claims. Open Payments data shows 64 records totaling $1,377. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $43,367 and ending at $61,385.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	782	11,111	$249,278
2016	806	11,208	$256,076
2017	824	9,572	$250,232
2018	792	6,476	$249,203
2019	750	6,590	$247,105
2020	659	4,685	$220,412
2021	608	4,624	$224,998
2022	620	5,361	$245,396
2023	683	4,487	$266,090
2024	706	5,117	$275,112

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	571	19,770	$1,316,252
2016	577	20,473	$1,319,665
2017	560	20,633	$1,315,474
2018	549	21,247	$1,200,060
2019	559	22,123	$1,351,190
2020	529	16,044	$1,032,977
2021	527	13,468	$964,049
2022	577	18,262	$1,313,235
2023	674	23,727	$1,750,124
2024	760	28,959	$2,245,169

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	122	642	$44,720
2016	103	865	$69,964
2017	54	772	$34,225
2018	82	800	$43,566
2019	72	772	$30,795
2020	50	717	$40,621
2021	53	323	$14,478
2022	70	557	$59,516
2023	54	545	$65,624
2024	33	478	$79,079

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99306	Initial nursing facility care with high level of medical decision making, per day, if using time, 50 minutes or more	205	248	$134
99309	Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes	84	135	$80
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	360	762	$79
99308	Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, 20 minutes or more	392	2,662	$52
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	326	650	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	750	13,303	$272,125
Januvia	Sitagliptin Phosphate	413	8,194	$154,462
Farxiga	Dapagliflozin Propanediol	223	6,082	$115,755
Jardiance	Empagliflozin	215	4,722	$96,469
Mounjaro	Tirzepatide	85	2,448	$86,708

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A6010	Collagen based wound filler, dry form, sterile, per gram of collagen	N	N/R	19	$22,198
B4154	Enteral formula, nutritionally complete, for special metabolic needs, excludes inherited disease of metabolism, includes altered composition of proteins, fats, carbohydrates, vitamins and/or minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit	N	N/R	38	$11,694
B4035	Enteral feeding supply kit; pump fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape	N	N/R	67	$10,443
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	23	$8,511
A6021	Collagen dressing, sterile, size 16 sq. in. or less, each	N	11	13	$8,210

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	64	$1,377	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mark D. Lafuria, MD?

Tedicare shows public-source Medicare data for Mark D. Lafuria, MD (NPI 1427181908), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mark D. Lafuria, MD have ACO affiliation data?

Mark D. Lafuria, MD is shown with ACO affiliation data for Health Leaders Network of Mississippi LLC (MSSP, ACO ID A5148).

What billing organization is linked to Mark D. Lafuria, MD?

Mark D. Lafuria, MD is linked to SWLHS LLC (billing NPI 1669494654) in the available physician profile data.

Does Mark D. Lafuria, MD have Open Payments data?

Mark D. Lafuria, MD has 64 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.